Enable AccessibilityEnable Accessibility


About Takeda Vaccines

For more than 70 years, Takeda has supplied vaccines to protect the health of people in Japan. Today, Takeda’s global vaccine business is applying innovation to tackle some of the world’s most challenging infectious diseases, such as dengue, COVID-19, pandemic influenza and Zika.

Takeda’s team brings an outstanding track record and a wealth of knowledge in vaccine development and manufacturing to advance a pipeline of vaccines to address some of the world’s most pressing public health needs.

Our mission is to develop and deliver innovative vaccines that tackle some of the toughest problems in public health and improve the lives of people around the world.

The Value of Vaccination

  • Vaccines prevent 3.5 to 5 million deaths each year and have transformed global public health.1
  • Vaccines are one of the most cost-effective ways to save lives.2
  • The global mortality rate for children has declined by more than 50% over the past 50 years, due in part to vaccines.3


  1. World Health Organization. Vaccines and Immunization. Retrieved May 25, 2022.
  2. Cost-effective. February 2020. Retrieved July 6, 2021.
  3. World Health Organization. Children: reducing mortality. September 2020. Retrieved September 23, 2021.